Tan C - Search Results

1

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.

Lin JT, Tong WP, Trippett TM, Niedzwiecki D, Tao Y, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Lin JT, et al. Among authors: tan c. Leuk Res. 1991;15(12):1191-6. doi: 10.1016/0145-2126(91)90189-z. Leuk Res. 1991. PMID: 1722550

2

Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia.

Trippett T, Schlemmer S, Elisseyeff Y, Goker E, Wachter M, Steinherz P, Tan C, Berman E, Wright JE, Rosowsky A, et al. Trippett T, et al. Among authors: tan c. Blood. 1992 Sep 1;80(5):1158-62. Blood. 1992. PMID: 1381235 Free article.

3

Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.

Göker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E, et al. Göker E, et al. Among authors: tan c. Blood. 1995 Jul 15;86(2):677-84. Blood. 1995. PMID: 7605998 Free article.

4

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Göker E, et al. Among authors: tan c. Leukemia. 1993 Jul;7(7):1000-4. Leukemia. 1993. PMID: 7686600

5

Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.

Meyers PA, Tan CT, Steinherz PG, Redner A. Meyers PA, et al. Among authors: tan ct. Cancer. 1989 Dec 15;64(12):2416-9. doi: 10.1002/1097-0142(19891215)64:12<2416::aid-cncr2820641203>3.0.co;2-y. Cancer. 1989. PMID: 2479459

6

Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies.

Tan CT, Wollner N, Trippett T, Goker E, Tong WP, Kheradpour A, Meyers PA, VanSyckle KM, Guarino L, Elisseyeff Y, et al. Tan CT, et al. J Clin Oncol. 1994 Sep;12(9):1955-62. doi: 10.1200/JCO.1994.12.9.1955. J Clin Oncol. 1994. PMID: 7521908 Clinical Trial.

7

Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.

Steinherz P, Meyers P, Wollner N, Redner A, Tan C. Steinherz P, et al. Among authors: tan c. Cancer. 1989 Apr 15;63(8):1472-6. doi: 10.1002/1097-0142(19890415)63:8<1472::aid-cncr2820630804>3.0.co;2-q. Cancer. 1989. PMID: 2647273

8

Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.

Steinherz PG, Redner A, Steinherz L, Meyers P, Tan C, Heller G. Steinherz PG, et al. Among authors: tan c. Cancer. 1993 Nov 15;72(10):3120-30. doi: 10.1002/1097-0142(19931115)72:10<3120::aid-cncr2820721038>3.0.co;2-q. Cancer. 1993. PMID: 8221579 Clinical Trial.

9

Phase I trial of homoharringtonine in children with refractory leukemia.

Tan CT, Luks E, Bacha DM, Steinherz P, Steinherz L, Mondora A. Tan CT, et al. Cancer Treat Rep. 1987 Dec;71(12):1245-8. Cancer Treat Rep. 1987. PMID: 3480043

10

Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Steinherz LJ, et al. Among authors: tan ct. JAMA. 1991 Sep 25;266(12):1672-7. JAMA. 1991. PMID: 1886191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,740 results

Search Page

Filters